Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
NCT03474965
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
- Locations
-
- University Of Alabama Birmingham, Alabama, United States
- Childrens National Hospital Washington D.C., District of Columbia, United States
- University of Florida Gainesville, Florida, United States
- Joe DiMaggio Childrens Hospital Hollywood, Florida, United States